Castle biosciences highlights progress for its pipeline atopic dermatitis gene expression profile test

Friendswood, texas--(business wire)--castle today provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis.
CSTL Ratings Summary
CSTL Quant Ranking